US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

321.39

+12.203.95%

Pre-market: 327.295.90+1.84%07:33 EST

Volume:269.23K

Turnover:85.40M

Market Cap:38.09B

PE:-193.33

High:323.20

Open:311.10

Low:306.73

Close:309.19

52wk High:355.30

52wk Low:170.99

Shares:118.51M

Float Shares:75.99M

Volume Ratio:1.43

T/O Rate:0.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6624

EPS(LYR):-6.1240

ROE:-4.98%

ROA:-1.06%

PB:10.10

PE(LYR):-52.48

Loading ...

Overview Company News Filings

Beone Medicines : Bernstein Raises Target Price to $362 From $259

THOMSON REUTERS

RBC Capital Remains a Buy on BeOne Medicines (ONC)

BEIGENE (06160) Grants Restricted Stock Units and Performance Stock Units

China's Young Consumers Set The Global Trend -- Barron's

BeOne Medicines (ONC) Has a New Rating from Barclays

China's Young Consumers Set the Global Trend. What They're Buying Now. -- Barrons.com

BEIGENE: Total of 63,000 American Depositary Shares Purchased by 3,932 Participants Under 2018 Employee Stock Purchase Plan

BEIGENE (06160) Issues 818,500 Shares Due to Stock Option Exercises

Capital Group Increases Stake in BEIGENE (06160) by Approximately 882,600 Shares at HK$348.12 per Share

Trump Administration Plans to Restrict Chinese Pharmaceuticals, BEIGENE Stock Plunges 12%

BeiGene's WCLC Data Shines! Hong Kong Stock Connect Innovative Drug ETF (520880) with 100% Purity Trades at High Premium! Institutions: Innovation Drug Bull Market May Be Far from Over

BeiGene (06160): New Subscription Period for 2018 Employee Stock Purchase Plan Runs from September 2 to February 27, 2026

FTSE China A50 Index Quarterly Review: Adds BeiGene (688235.SH), Wuxi Apptec Co.,Ltd. (603259.SH), Removes China National Nuclear Power Co.,Ltd. (601985.SH) and Others

US Stock Movement | BeiGene (ONC.US) Surges Over 9% as H1 2025 Revenue Grows 46%

Stock Track | BeOne Medicines (ONC) Soars 9.54% Pre-Market Following Guggenheim's Buy Rating Reiteration

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Ahead of Inflation Data

MT Newswires Live

BeOne Medicines Says Phase 2 Study for Investigational Cancer Drug Sonrotoclax Met Primary Endpoint

MT Newswires Live

BEIGENE (06160): Sonrotoclax Achieves Positive Clinical Results for Treating Mantle Cell Lymphoma Patients

BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment

MT Newswires Live

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ONC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":321.39,"timestamp":1762376400000,"preClose":309.19,"halted":0,"volume":269232,"hourTrading":{"tag":"盘前","latestPrice":327.29,"preClose":321.39,"latestTime":"07:33 EST","volume":287,"amount":93597.6454,"timestamp":1762432434298},"delay":0,"floatShares":75991800,"shares":118513677,"eps":-1.662384,"marketStatus":"Pre-Mkt","change":12.2,"latestTime":"11-06 07:35:35 EST","open":311.1,"high":323.2,"low":306.73,"amount":85399835.78208001,"amplitude":0.053268,"askPrice":327.29,"askSize":94,"bidPrice":324,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.662384,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762439400000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":321.39,"preHourTrading":{"tag":"盘前","latestPrice":327.29,"preClose":321.39,"latestTime":"07:33 EST","volume":287,"amount":93597.6454,"timestamp":1762432434298},"postHourTrading":{"tag":"盘后","latestPrice":321.39,"preClose":321.39,"latestTime":"19:58 EST","volume":2962,"amount":952087.7,"timestamp":1762390711502},"volumeRatio":1.4337302298478352,"impliedVol":0.5497,"impliedVolPercentile":0.9387},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75991800,"roa":"-1.06%","roe":"-4.98%","lyrEps":-6.124009,"volumeRatio":1.4337302298478352,"shares":118513677,"dividePrice":0,"high":323.2,"amplitude":0.053268,"preClose":309.19,"low":306.73,"week52Low":170.99,"pbRate":"10.10","psRate":"8.35","week52High":355.3,"institutionHeld":0,"latestPrice":321.39,"committee":-0.807692,"eps":-1.662384,"divideRate":0,"volume":269232,"delay":0,"ttmEps":-1.662384,"open":311.1,"prevYearClose":184.71,"prevWeekClose":310.48,"prevMonthClose":310.48,"prevQuarterClose":340.7,"fiveDayClose":314.85,"twentyDayClose":351.09,"sixtyDayClose":288.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-11-06","symbol":"ONC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.72,"defaultRemindTime":1762462800000,"name":null,"time":"Post Market","dateTimestamp":1762405200000,"actualEps":null},{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-Market","dateTimestamp":1756526400000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.6667,"hold":0.0417,"sell":0.0417,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":24,"updateTime":1758171600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-11-04","current":-193.330783,"percent":0.124654,"low":-217.585346,"twenty":-89.138637,"median":-41.903376,"eighty":-24.138511,"high":-19.234246,"avg":-69.696555,"sd":62.454916,"marketCap":34333182904},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-29","current":-184.552827,"twenty":-72.8475,"median":-40.343171,"eighty":-23.581122,"marketCap":32784148770},{"date":"2025-09-05","current":-197.417514,"twenty":-73.864189,"median":-40.425269,"eighty":-23.723244,"marketCap":35069444682},{"date":"2025-09-12","current":-208.147892,"twenty":-74.224679,"median":-40.801852,"eighty":-23.82061,"marketCap":36975599617},{"date":"2025-09-19","current":-212.503459,"twenty":-75.66857,"median":-40.932054,"eighty":-23.865007,"marketCap":37749326897},{"date":"2025-09-26","current":-203.715512,"twenty":-76.587723,"median":-41.008162,"eighty":-23.928977,"marketCap":36188227257},{"date":"2025-10-03","current":-213.916471,"twenty":-77.910534,"median":-41.112345,"eighty":-23.950329,"marketCap":38000335866},{"date":"2025-10-10","current":-208.109485,"twenty":-81.639564,"median":-41.598105,"eighty":-24.044918,"marketCap":36968777077},{"date":"2025-10-17","current":-197.090466,"twenty":-85.2662,"median":-41.668284,"eighty":-24.084563,"marketCap":35011347487},{"date":"2025-10-24","current":-192.138725,"twenty":-87.584871,"median":-41.753651,"eighty":-24.09529,"marketCap":34131715179},{"date":"2025-10-31","current":-191.016991,"twenty":-89.061223,"median":-41.811067,"eighty":-24.120226,"marketCap":33932449287},{"date":"2025-11-04","current":-193.272853,"twenty":-89.138637,"median":-41.903376,"eighty":-24.138511,"marketCap":34333182904}],"updateTime":1762397388033},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574130490","title":"Beone Medicines : Bernstein Raises Target Price to $362 From $259","url":"https://stock-news.laohu8.com/highlight/detail?id=2574130490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574130490?lang=en_us&edition=fundamental","pubTime":"2025-10-09 17:46","pubTimestamp":1760003184,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nFWN3VQ12Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONC","BK4526","688235","BK4585","BK4139","BK0239"],"gpt_icon":0},{"id":"2574831973","title":"RBC Capital Remains a Buy on BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574831973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574831973?lang=en_us&edition=fundamental","pubTime":"2025-10-09 00:36","pubTimestamp":1759941361,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on BeOne Medicines today and set a price target of $374.00. The company’s shares opened...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-beone-medicines-onc-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-beone-medicines-onc-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","BK4207","ONC","LU0029864427.USD","BK4139","BK4585","LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","BK4526","LU0708994859.HKD"],"gpt_icon":0},{"id":"1143466915","title":"BEIGENE (06160) Grants Restricted Stock Units and Performance Stock Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1143466915","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143466915?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:20","pubTimestamp":1759926020,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced that on September 30, 2025, the Board's Compensation Committee granted restricted stock units involving a total of 36,000 American Depositary Shares to 237 grantees, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU0307460666.USD","06160","LU1770034418.SGD","LU1969619763.USD","BK4139","BK1500","ONC","BK4585","LU1303224171.USD","LU1251922891.USD","BK1161","BK1588","BK4526","LU1719994722.HKD","BK1583","688235","LU2328871848.SGD","LU0588546209.SGD"],"gpt_icon":0},{"id":"2568321218","title":"China's Young Consumers Set The Global Trend -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2568321218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568321218?lang=en_us&edition=fundamental","pubTime":"2025-09-20 09:31","pubTimestamp":1758331860,"startTime":"0","endTime":"0","summary":"Zak Dychtwald, founder of the research and advisory firm YCG Bridgeworks, spends his time traveling the world to help companies understand China and the developing trends in his adopted country that will reshape global business.Dychtwald grew up on the West Coast of the U.S. in a home of demographers and moved to Chengdu, China, after graduating from Columbia University. Initially he worked odd jobs such as tutoring and videogame translation, before diving more deeply into researching China's equivalent of millennials. YCG stands for Young China Group.Zak Dychtwald: The whole boomers/Gen Z/millennial categorization is a U.S. and Western European--based construct for generations that doesn't work for China because Chinese demographics change so rapidly. China generations are typically viewed on a 10-year basis, with savvy marketers taking even a narrower look.Yet there is double-digit unemployment among younger Chinese. There have been layoffs in the tech sector, and the economy's growt","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0181495838.USD","LU1960683339.HKD","BK4543","LU0080751232.USD","ONC","BK1588","LU0541501648.USD","LU1568876251.USD","LU2242644610.SGD","BK1586","MIUmain","LU0531971595.HKD","LU0163747925.USD","LU1282649067.USD","LU0456827905.SGD","LU1044875133.USD","HTCD.SI","LU1770034418.SGD","LU0634319403.HKD","HXXD.SI","BK1618","LU1675838814.USD","LU0251144936.SGD","89988","ALBmain","LU1568876335.HKD","01810","LU0541502299.USD","LU0173614495.USD","LU1226287875.USD","LU0320764599.SGD","BK4575","HBBD.SI","SG9999001226.SGD","LU0611395673.USD","BK4614","LU2177674079.SGD","LU0029875118.USD","LU1105468828.SGD","XIACY","TCHmain","LU1224444064.USD","LU1642822792.SGD","LU0831103253.SGD","LU1152091168.USD","81810"],"gpt_icon":1},{"id":"2568542439","title":"BeOne Medicines (ONC) Has a New Rating from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2568542439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568542439?lang=en_us&edition=fundamental","pubTime":"2025-09-18 15:26","pubTimestamp":1758180376,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson initiated coverage with a Buy rating on BeOne Medicines today and set a price target of $385.00. The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-has-a-new-rating-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-has-a-new-rating-from-barclays-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","ONC"],"gpt_icon":0},{"id":"2568579429","title":"China's Young Consumers Set the Global Trend. What They're Buying Now. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2568579429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568579429?lang=en_us&edition=fundamental","pubTime":"2025-09-18 15:00","pubTimestamp":1758178800,"startTime":"0","endTime":"0","summary":"Zak Dychtwald, founder of the research and advisory firm YCG Bridgeworks, spends his time traveling the world to help companies understand China and the developing trends in his adopted country that will reshape global business.Dychtwald grew up on the West Coast of the U.S. in a home of demographers and moved to Chengdu, China, after graduating from Columbia University. Initially he worked odd jobs such as tutoring and videogame translation, before diving more deeply into researching China's equivalent of millennials. YCG stands for Young China Group.Zak Dychtwald: The whole boomers/Gen Z/millennial categorization is a U.S. and Western European--based construct for generations that doesn't work for China because Chinese demographics change so rapidly. China generations are typically viewed on a 10-year basis, with savvy marketers taking even a narrower look.Yet there is double-digit unemployment among younger Chinese. There have been layoffs in the tech sector, and the economy's growt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1548497426.USD","LU1115378108.SGD","LU0173614495.USD","HXXD.SI","LU0130103400.USD","BK1501","LU0320764755.SGD","LU1226288170.HKD","BK1607","LU2476274308.USD","BK1608","LU0384037296.USD","SG9999018857.SGD","LU0329678337.USD","89988","LU0067412154.USD","LU0117841782.USD","LU0540923850.HKD","ALBmain","LU2237443978.SGD","LU0127658192.USD","XIACY","LU2247934214.USD","IE0003851619.USD","MIUmain","LU0738912210.USD","LU1807302812.USD","LU0561508036.HKD","LU1226287792.SGD","SG9999007991.SGD","HBBD.SI","TCHmain","LU0149534421.HKD","LU0128522157.USD","LU0499858602.USD","LU2399975544.HKD","LU1831875114.USD","01810","LU0819121731.USD","LU0164880469.USD","81810","HTCD.SI","LU1102505929.USD","ONC","IE00B031J352.USD","LU0054450605.USD"],"gpt_icon":1},{"id":"1129337830","title":"BEIGENE: Total of 63,000 American Depositary Shares Purchased by 3,932 Participants Under 2018 Employee Stock Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1129337830","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129337830?lang=en_us&edition=fundamental","pubTime":"2025-09-13 12:01","pubTimestamp":1757736078,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced that during the subscription period ending on August 29, 2025, from March 3, 2025 to August 29, 2025, a total of 63,000 American Depositary Shares were purchased by 3,932...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4a0607946191feca67520e67fc0edf19","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","688235","BK1161","BK1588","BK1583","LU2328871848.SGD","LU1770034418.SGD","LU1251922891.USD","LU1719994722.HKD","LU1969619763.USD","06160","LU0588546209.SGD","ONC","BK4585","LU1303224171.USD","BK4526","BK0239","BK4139","LU0307460666.USD"],"gpt_icon":1},{"id":"1180780615","title":"BEIGENE (06160) Issues 818,500 Shares Due to Stock Option Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=1180780615","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180780615?lang=en_us&edition=fundamental","pubTime":"2025-09-12 15:20","pubTimestamp":1757661622,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced that on September 11, 2025, the company issued 818,500 ordinary shares pursuant to the Fifth Amended and Restated 2018 Employee Stock Option Plan.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU2328871848.SGD","LU1719994722.HKD","BK4526","BK1500","BK4139","LU0307460666.USD","BK1161","06160","LU1969619763.USD","ONC","LU1251922891.USD","BK0239","688235","LU1303224171.USD","LU1770034418.SGD","BK1588","BK4585","BK1583"],"gpt_icon":0},{"id":"1167845040","title":"Capital Group Increases Stake in BEIGENE (06160) by Approximately 882,600 Shares at HK$348.12 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1167845040","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167845040?lang=en_us&edition=fundamental","pubTime":"2025-09-11 19:22","pubTimestamp":1757589741,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 9, Capital Group increased its holdings in BEIGENE (06160) by 882,648 shares at HK$348.12 per share, representing a total...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU0588546209.SGD","BK4139","688235","LU1719994722.HKD","LU1251922891.USD","BK4526","LU1969619763.USD","BK1500","BK1161","06160","BK1583","BK1588","LU2328871848.SGD","BK4585","LU0307460666.USD","LU1303224171.USD","ONC","LU1770034418.SGD"],"gpt_icon":0},{"id":"1185659472","title":"Trump Administration Plans to Restrict Chinese Pharmaceuticals, BEIGENE Stock Plunges 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185659472","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185659472?lang=en_us&edition=fundamental","pubTime":"2025-09-10 22:07","pubTimestamp":1757513227,"startTime":"0","endTime":"0","summary":"According to reports, the Trump administration is drafting an executive order that plans to impose strict restrictions on Chinese pharmaceuticals, particularly experimental drugs. This policy aims to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","LU1969619763.USD","BK0239","LU1719994722.HKD","BK1583","688235","LU1770034418.SGD","LU2328871848.SGD","LU1303224171.USD","BK4139","ONC","BK1500","BK4585","BK1588","LU0588546209.SGD","06160","BK1161","BK4526","LU0307460666.USD"],"gpt_icon":0},{"id":"1156502187","title":"BeiGene's WCLC Data Shines! Hong Kong Stock Connect Innovative Drug ETF (520880) with 100% Purity Trades at High Premium! Institutions: Innovation Drug Bull Market May Be Far from Over","url":"https://stock-news.laohu8.com/highlight/detail?id=1156502187","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156502187?lang=en_us&edition=fundamental","pubTime":"2025-09-10 13:51","pubTimestamp":1757483468,"startTime":"0","endTime":"0","summary":"On September 10th, the Hong Kong Stock Connect innovative drug sector underwent adjustments, with the 100% pure Hong Kong Stock Connect Innovative Drug ETF (520880) continuing underwater fluctuations...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","BK4614","LU1969619763.USD","HSCEI","LU0588546209.SGD","LU1719994722.HKD","YANG","06160","515120","688235","159992","BK1500","BK1588","07226","BK1161","BK4526","BK1583","LU2328871848.SGD","LU1251922891.USD","BK1574","BK4585","LU1770034418.SGD","BK0239","LU1303224171.USD","BK4139","HSTECH","ONC","06978"],"gpt_icon":1},{"id":"1183227649","title":"BeiGene (06160): New Subscription Period for 2018 Employee Stock Purchase Plan Runs from September 2 to February 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1183227649","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183227649?lang=en_us&edition=fundamental","pubTime":"2025-09-04 16:44","pubTimestamp":1756975458,"startTime":"0","endTime":"0","summary":"BeiGene (06160) announced that the new subscription period for its 2018 Employee Stock Purchase Plan will run from September 2, 2025, to February 27, 2026. Eligible employees will purchase shares...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1500","688235","06160","LU0307460666.USD","LU2328871848.SGD","BK1588","LU1770034418.SGD","ONC","BK4526","LU1303224171.USD","BK0239","LU1719994722.HKD","BK4585","LU1251922891.USD","BK1583","LU1969619763.USD","LU0588546209.SGD","BK1161"],"gpt_icon":0},{"id":"1178094592","title":"FTSE China A50 Index Quarterly Review: Adds BeiGene (688235.SH), Wuxi Apptec Co.,Ltd. (603259.SH), Removes China National Nuclear Power Co.,Ltd. (601985.SH) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1178094592","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178094592?lang=en_us&edition=fundamental","pubTime":"2025-09-03 18:16","pubTimestamp":1756894595,"startTime":"0","endTime":"0","summary":"On September 3rd, FTSE Russell announced quarterly review changes to the FTSE China 50 Index and FTSE China A50 Index. These changes will take effect after market close on Friday, September 19, 2025...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245094.SGD","LU0456842615.SGD","BK1515","LU1046422090.SGD","LU0469268626.HKD","LU2488822045.USD","LU1224709979.USD","06618","603259","BK1591","06160","LU1997245177.USD","BK1175","688235","LU2125910500.SGD","BK1147","BK1161","BK1500","LU1303224171.USD","BK1141","LU0588546209.SGD","BK0271","BK1589","LU0516422366.SGD","LU1808992512.USD","LU0516422440.USD","LU1969619763.USD","BK4526","LU0051755006.USD","LU0173614495.USD","BK1594","03692","BK1247","BK1583","LU0516423091.SGD","86618","BK0035","BK0196","601985","159593","BK1576","LU1979443071.USD","LU0320764599.SGD","BK0188","LU0307460666.USD","06886","BK1191","BK0239","LU0052750758.USD","LU0264606111.USD","BK1592","ONC","BK0012","BK1142","LU0287142896.SGD","LU2045819591.USD","BK0028","SG9999001093.SGD","LU1166156734.SGD","02359","BK1588","LU0572940350.SGD","BK4585","BK0183","LU0516423174.USD","BK1571","LU0572939691.SGD","LU1719994722.HKD","BK1564","LU1770034418.SGD","LU2495084118.USD","BK0179","LU2328871848.SGD","LU1251922891.USD","BK1615","BK0201","LU0702159699.USD","BK0216","LU0737861699.HKD","01378","LU1934453819.USD","BK4139","LU0516422952.EUR","LU0708995583.HKD","LU1997244956.HKD","LU2242644610.SGD","LU0456827905.SGD"],"gpt_icon":1},{"id":"1121569039","title":"US Stock Movement | BeiGene (ONC.US) Surges Over 9% as H1 2025 Revenue Grows 46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121569039","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121569039?lang=en_us&edition=fundamental","pubTime":"2025-09-02 21:50","pubTimestamp":1756821027,"startTime":"0","endTime":"0","summary":"On Tuesday, BeiGene (ONC.US) surged over 9% to $334.20. According to financial results, BeiGene achieved total operating revenue of 17.518 billion yuan in the first half of 2025, representing a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","688235","BK0239","LU0307460666.USD","LU1719994722.HKD","BK4139","BK4526","LU1251922891.USD","BK1583","BK1161","LU2328871848.SGD","LU0588546209.SGD","LU1969619763.USD","LU1770034418.SGD","BK1588","LU1303224171.USD","BK1500","BK4585","ONC"],"gpt_icon":0},{"id":"1190123890","title":"Stock Track | BeOne Medicines (ONC) Soars 9.54% Pre-Market Following Guggenheim's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1190123890","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190123890?lang=en_us&edition=fundamental","pubTime":"2025-09-02 21:34","pubTimestamp":1756820087,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) stock is experiencing a significant surge in pre-market trading on Tuesday, soaring 9.54% following a positive analyst report. The sharp uptick comes as investors react to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"2563302808","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Ahead of Inflation Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2563302808","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563302808?lang=en_us&edition=fundamental","pubTime":"2025-08-29 20:19","pubTimestamp":1756469953,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3% and the actively traded Invesco QQQ Trust (QQQ) retreated 0.5% in Friday's pre-bell activity, as investors await crucia","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d92386cd941704fe36f9c01cc9dc6ea5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IWM","SLV","IGM","XLE","BITO","IGV","IYH","VHT.AU","RTH.AU","XLP","IBB","VDC","FAZ","XRT","XLY","EEM","USO","GLD","XLI","UNG","QQQ","XSD","SPY.AU","EETH","EQR","PMR","IREN","FDN","BETH","VHT",".IXIC","SPY","SOXX","FAS","IYK","XLV",".SPX","IYJ","VIS","XLF","IPK","XLK","RTH","MRVL","BABA",".DJI","IYW","ONC","IYE","EXI"],"gpt_icon":0},{"id":"2563413470","title":"BeOne Medicines Says Phase 2 Study for Investigational Cancer Drug Sonrotoclax Met Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2563413470","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563413470?lang=en_us&edition=fundamental","pubTime":"2025-08-29 18:30","pubTimestamp":1756463425,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) said Friday its phase 1/2 study of sonrotoclax met the primary endpoint of overall response rate in adult patients with relapsed/refractory mantle cell lymphoma, or MCL, after tr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4526","MDCO","ONC","BK4139"],"gpt_icon":0},{"id":"1109607565","title":"BEIGENE (06160): Sonrotoclax Achieves Positive Clinical Results for Treating Mantle Cell Lymphoma Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1109607565","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109607565?lang=en_us&edition=fundamental","pubTime":"2025-08-29 18:24","pubTimestamp":1756463095,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced that on August 29, 2025, the company reported positive results from a Phase 1/2 clinical study (BGB-11417-201) of sonrotoclax, a next-generation investigational BCL2...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","688235","BK1583","LU1969619763.USD","LU0588546209.SGD","BK0239","BK1161","06160","BK1588","BK4139","BK4526","BK1500","LU2328871848.SGD","BK4585","LU0307460666.USD"],"gpt_icon":0},{"id":"2562642717","title":"BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2562642717","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562642717?lang=en_us&edition=fundamental","pubTime":"2025-08-27 18:37","pubTimestamp":1756291075,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Wednesday that the European Commission has approved Tevimbra, in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by Tevimbra alone after surgery, for adults with resectable non-small cell lung cancer at high risk of recurrence.The company said the approval is based on the final analysis of Phase 3 trial data, which showed that the Tevimbra regimen significantly improved overall survival compared to chemotherapy plus placebo.With a median follow-up of 38.5 months, the study also confirmed sustained benefits in event-free survival, major pathological response, and pathological complete response across various patient subgroups-regardless of PD-L1 levels, disease stage, or tumor type, the company said.Tevimbra is already approved in the EU for four indications related to lung cancer and other cancer treatments.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","ONC","BK4139","BK4585","BK4156"],"gpt_icon":0},{"id":"2562324229","title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324229","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562324229?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:22","pubTimestamp":1756128164,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower pre-bell Monday, with the Health Care Select Sector SPDR Fund  inactive and the iShares Biotechnology ETF  down 0.2%.Argenx  stock was nearly 4% higher after the company said a phase 3 study of its drug Vyvgart met its primary endpoint in treating patients with AChR-Ab seronegative generalized myasthenia gravis, an autoimmune disease.Axogen  shares were down more than 10% after the company said the US Food and Drug Administration has extended the review deadline for its marketing application for the Avance Nerve Graft by three months.BeOne Medicines  shares were up more than 2% after the company said it has agreed to sell its royalty rights, excluding China, on Amgen's  lung cancer drug, Imdelltra, to Royalty Pharma  for up to $950 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0868494617.USD","BK4588","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4599","BK4566","BK4139","BK4526","BK4534","AMGN","LU0320765992.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2089984988.USD","BK4082","SG9999001440.SGD","BK4007","LU2112291526.USD","LU0058720904.USD","BK4533","BK4505","BK4581","LU0889565916.HKD","LU2242652126.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","ARGX","XLV","IBB","LU2242646821.SGD","LU1023059063.AUD","IE00B2B36J28.USD","AXGN","BK4585","LU1061106388.HKD","LU1983299246.USD","ONC","LU0122379950.USD","RPRX","IE0002141913.USD","LU0289739699.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}]}}